MX2023002686A - Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos. - Google Patents

Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos.

Info

Publication number
MX2023002686A
MX2023002686A MX2023002686A MX2023002686A MX2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A MX 2023002686 A MX2023002686 A MX 2023002686A
Authority
MX
Mexico
Prior art keywords
oxacycloalkyl
sulphamoyl
moiety
containing alkyl
urea derivatives
Prior art date
Application number
MX2023002686A
Other languages
English (en)
Spanish (es)
Inventor
David Harrison
Mark G Bock
Jane E Scanlon
Original Assignee
Nodthera Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nodthera Ltd filed Critical Nodthera Ltd
Publication of MX2023002686A publication Critical patent/MX2023002686A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2023002686A 2020-09-04 2021-09-03 Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos. MX2023002686A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063074521P 2020-09-04 2020-09-04
PCT/US2021/049001 WO2022051582A1 (en) 2020-09-04 2021-09-03 Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof

Publications (1)

Publication Number Publication Date
MX2023002686A true MX2023002686A (es) 2023-04-03

Family

ID=77951864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023002686A MX2023002686A (es) 2020-09-04 2021-09-03 Derivados de sulfamoil urea que contienen una porcion alquil-oxacicloalquilo y usos de los mismos.

Country Status (13)

Country Link
US (1) US20240043410A1 (enExample)
EP (1) EP4208459A1 (enExample)
JP (1) JP7865948B2 (enExample)
KR (1) KR20230061505A (enExample)
CN (1) CN116783184A (enExample)
AR (1) AR123435A1 (enExample)
AU (1) AU2021336518B2 (enExample)
BR (1) BR112023003792A2 (enExample)
CA (1) CA3191410A1 (enExample)
IL (1) IL301055A (enExample)
MX (1) MX2023002686A (enExample)
TW (1) TWI916398B (enExample)
WO (1) WO2022051582A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
HUE067378T2 (hu) 2019-06-12 2024-10-28 Nodthera Ltd Szulfonilurea származékok és alkalmazásaik
JP7661248B2 (ja) 2019-06-12 2025-04-14 ノッドセラ リミテッド スルホニル尿素誘導体及びその使用
KR20260115622A (ko) * 2023-11-17 2026-07-24 노드테라 리미티드 우레아 유도체의 제조 방법
CN122555701A (zh) 2023-11-17 2026-08-11 诺瑟拉有限公司 脲衍生物的形式和相关用途
TW202545527A (zh) * 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
DK1270565T3 (da) 1997-01-29 2004-10-04 Pfizer 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater
JP6929792B2 (ja) * 2015-02-16 2021-09-01 ザ ユニバーシティ オブ クィーンズランド スルホニル尿素及び関連化合物並びにその使用
JP7412328B2 (ja) 2017-07-24 2024-01-12 ノバルティス アーゲー Nlrp活性に関連する状態を治療するための化合物及び組成物
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
SG11202101480XA (en) 2018-08-15 2021-03-30 Inflazome Ltd Novel sulfonamideurea compounds

Also Published As

Publication number Publication date
IL301055A (en) 2023-05-01
CA3191410A1 (en) 2022-03-10
TWI916398B (zh) 2026-03-01
BR112023003792A2 (pt) 2023-03-28
AU2021336518A1 (en) 2023-03-23
EP4208459A1 (en) 2023-07-12
AU2021336518B2 (en) 2026-05-21
AR123435A1 (es) 2022-11-30
JP2023540733A (ja) 2023-09-26
US20240043410A1 (en) 2024-02-08
KR20230061505A (ko) 2023-05-08
JP7865948B2 (ja) 2026-05-26
WO2022051582A1 (en) 2022-03-10
TW202229265A (zh) 2022-08-01
CN116783184A (zh) 2023-09-19

Similar Documents

Publication Publication Date Title
ZA202000425B (en) Selective inhibitors of nlrp3 inflammasome
MX2020006399A (es) Derivados de sulfonil urea.
MX2025011899A (es) Compuestos de pirido[4,3-d]pirimidina
BR112023003792A2 (pt) Derivados de sulfamoil ureia contendo porção alquil-oxacicloalquila e usos dos mesmos
EP4331668A3 (en) Compounds for inhibiting nlrp3 and uses thereof
MX2022008066A (es) Compuestos triciclicos sustituidos.
MX2024000234A (es) Inhibidores del inflamasoma nlrp3.
EA201992152A1 (ru) Химические соединения
MX2020009738A (es) Derivados de imidazolidin-2-ona sustituidos como inhibidores de prmt5.
UA86614C2 (ru) Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
WO2004071400A3 (en) Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
EA201071040A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40
JOP20230252A1 (ar) مشتقات فسفورية كمثبطات sos1 جديدة
MX2025011886A (es) Derivados biciclicos semisaturados y usos relacionados
MX2026000683A (es) Derivados de heteroarilo sustituidos con diaminociclopentilo, su uso y su metodo de preparacion
MX2024014315A (es) Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas
MY195576A (en) Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof
WO2025014877A3 (en) Triazolo wrn inhibitors
MX2025000635A (es) Compuestos cíclicos y métodos de utilización de estos
CO2024015371A2 (es) Derivados de oxoindolinil amida para inhibir nlrp3 y usos de los mismos
MX2023012039A (es) Compuestos bicíclicos fusionados sustituidos como inhibidores de parp y uso de estos.
MX2025001865A (es) Compuestos de piridinona sustituida como inhibidores de cbl-b
MX2025010952A (es) Derivados de amida para inhibir el gen nlrp3 y usos de los mismos
MX2021008930A (es) Derivados de carbamato y sus usos.
WO2024086789A3 (en) Mutant pi3k-alpha inhibitors and their use as pharmaceuticals